Abstract
Background 1H-MRS is increasingly used in basic and clinical research to explain brain function and alterations respectively. In psychosis research it is now one of the main tools to investigate imbalances in the glutamatergic system. Interestingly, however, the findings are extremely variable even within patients of similar disease states. One reason may be the variability in analysis strategies, despite suggestions for standardization. Therefore, our study aimed to investigate the extent to which the basis set configuration – which metabolites are included in the basis set used for analysis – would affect the spectral fit and estimated glutamate (Glu) concentrations in the anterior cingulate cortex (ACC), and whether any changes in levels of glutamate would be associated with psychotic-like experiences and autistic traits.
Methods To ensure comparability, we utilized five different exemplar basis sets, used in research, and two different analysis tools, r-based spant applying the ABfit method and Osprey using the LCModel.
Results Our findings revealed that the types of metabolites included in the basis set significantly affected the glutamate concentration. We observed that three basis sets led to more consistent results across different concentration types (i.e., absolute Glu in mol/kg, Glx (glutamate+glutamine), Glu/tCr), spectral fit and quality measurements. Interestingly, all three basis sets included phosphocreatine. Importantly, our findings also revealed that glutamate levels were differently associated with both schizotypal and autistic traits depending on basis set configuration and analysis tool, with the same three basis sets showing more consistent results.
Conclusions Our study highlights that scientific results may be significantly altered depending on the choices of metabolites included in the basis set, and with that emphasizes the importance of carefully selecting the configuration of the basis set to ensure accurate and consistent results, when using MR spectroscopy. Overall, our study points out the need for standardized analysis pipelines and reporting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the doctoral program Translationale Medizin of the Technical University of Munich funded by Else Kröner-Fresenius-Stiftung (EKFS) to VD.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The medical research ethics committee of the Technical University of Munich gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The abstract was structured for more clarity. In the background section, we clarified the goal of the study - increasing the awareness of the impact of the basis set composition. In the methods section, the subheader "2.6Quality assessment" was added to give more details on the MRS analysis quality parameters (SNR, FWHM and CRLB). In the supplements, we added the subheader "4.3 Association between the concentrations and traits" to strengthen our finding that those basis sets including phosphocreatine (PCr) showed more consistent results. Figure S2 was attached to the supplements showing the group comparisons and Spearman correlations for those newly created basis sets.
Data Availability
The datasets generated and/or analysed during the current study are available in the OSF repository, [https://osf.io/zjtd8/?view_only=9763e1e752e7409892730ecafed71bf7].
https://osf.io/zjtd8/?view_only=9763e1e752e7409892730ecafed71bf7
6 List of abbreviations
- 1H-MRS
- Proton Magnetic Resonance Spectroscopy
- ABfit
- Adaptive baseline fitting algorithm
- ACC
- Anterior cingulate cortex
- AQ
- Autism Spectrum Quotient
- ASD
- Autism spectrum disorder
- Asp
- Aspartate
- AWSO
- Automatic Water Suppression Optimization
- BW
- Spectral bandwidth
- Cr
- Creatine
- CRLB
- Cramer-Rao lower bounds
- CSF
- Cerebrospinal fluid
- FWHM
- Full Width at Half Maximum
- GABA
- Gamma-aminobutyric acid
- Glc
- Glucose
- Gln
- Glutamine
- Glu
- Glutamate
- Gly
- Glycine
- GM
- Grey matter
- GPC
- Glycerophosphocholine
- GSH
- Glutathione
- HSVD
- Hankel singular value decomposition
- Lac
- Lactate
- LCM
- LCModel
- MI
- Myo-Inositol
- MPRAGE
- Magnetization prepared rapid gradient echo
- MRS
- Magnetic Resonance Spectroscopy
- NAA
- N-acetylaspartate
- NAAG
- N-acetylaspartylglutamate
- NMDA
- N-methyl-D-aspartate
- PCh
- Phosphocholine
- PCr
- Phosphocreatine
- PE
- Phosphoryl ethanolamine
- PRESS
- Point Resolved Spectroscopy Sequence
- SI
- Scyllo-Inositol
- SNR
- Signal-to-Noise Ratio
- spant
- Spectroscopy Analysis Tools
- SPQ
- Schizotypal Personality Questionnaire
- Tau
- Taurine
- TE
- Time of echo
- TR
- Repetition Time
- WM
- White matter
